Kristine Peterson Paratek Pharmaceuticals, Inc. (PRTK) insider trading activity

Kristine Peterson is Director of Paratek Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of PRTK, which is worth approximately $0. The most recent transaction as insider was on Sep 21, 2023, when has been sold 79,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Kristine Peterson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 21 2023	SELL Sale (or disposition) back to the issuer	-	79,000 Reduced 100.0%	0 Common Stock
Feb 08 2023	BUY Grant, award, or other acquisition	-	20,000 Added 20.2%	79,000 Common Stock
Feb 16 2022	BUY Grant, award, or other acquisition	-	20,000 Added 25.32%	59,000 Common Stock
Feb 18 2021	BUY Grant, award, or other acquisition	-	9,000 Added 18.75%	39,000 Common Stock

Also insider at

IMCR

Immunocore Holdings plc Healthcare

IMGN

ImmunoGen, Inc. Healthcare

Director

ENTA

ENANTA PHARMACEUTICALS INC Healthcare

Director

AMRN

AMARIN CORP PLCUK Healthcare

AVBP

ArriVent Biopharma, Inc.

Director